Insider Tracker SEC Form 4 insider trades
← All clusters
SER

Serina Therapeutics, Inc.

AI summary Multiple directors acquire shares in open-market transactions following first-quarter results and private placement financing.

52
Insider Score Band below 60
Research score
43
AI adjustment
+9

Research score, not a recommendation.

Total bought$78.0K7 Form 4 purchases
Distinct insiders4open-market buyers
Lead insiderWILSON KAREN JDirector
Cluster window2026-05-19 → 2026-07-07active

Market data

Live quote and chart from Yahoo Finance, loaded through this server. Insider purchases are marked on the chart.

–

Why this score

Research score: a weighted blend of the five factors, times the routine and offering discounts, minus the selling penalty.

Breadth number & diversity of participating insiders
63%
Seniority executive rank of buyers (CEO/CFO/Director)
60%
Commitment purchase size relative to company & holdings
90%
Context buying into stock weakness signals conviction
100%
Timing coordinated purchases within a tight window
74%
Routine-purchase discount × 1.00
Company-type / offering discount × 1.00
Net insider selling penalty − 0

Why are they buying?

AI · discretionary · catalyst credible · documented

Insiders made discretionary open-market purchases shortly after the company reported first-quarter 2026 financial results, highlighted ongoing clinical progress for SER-252 in advanced Parkinson's disease, and closed a $21.2 million private placement financing.

The company reported $24.5 million in cash and cash equivalents as of March 31, 2026, alongside gross proceeds of $5.2 million received in April from the PIPE financing, strengthening its balance sheet as it advances its Phase 1b registrational clinical study.

Stock Price & Insider Purchase History

Daily close price with open-market insider purchases plotted over time

Loading price history…

Transactions

7 Form 4 trades · 4 insiders Sign in to download CSV
Purchases in this cluster, grouped by insider, largest first
Date Insider Role Shares Price Value Filing
2026-05-21 → 2026-06-12 WILSON KAREN J history of WILSON KAREN J's purchases Director 30,100 $1.82 avg $54.8K
2026-05-21 WILSON KAREN J 10,000 $1.77 $17.7K SEC filing for WILSON KAREN J (opens in a new tab)
2026-05-22 WILSON KAREN J 10,000 $1.93 $19.3K SEC filing for WILSON KAREN J (opens in a new tab)
2026-06-11 WILSON KAREN J 5,100 $1.75 $8.9K SEC filing for WILSON KAREN J (opens in a new tab)
2026-06-12 WILSON KAREN J 5,000 $1.77 $8.8K SEC filing for WILSON KAREN J (opens in a new tab)
2026-05-19 Marshall Richard Peter history of Marshall Richard Peter's purchases Director 12,183 $1.65 $20.1K SEC filing for Marshall Richard Peter (opens in a new tab)
2026-07-07 Brannan Stephen K. history of Brannan Stephen K.'s purchases Director 1,000 $2.03 $2.0K SEC filing for Brannan Stephen K. (opens in a new tab)
2026-05-22 Venkatesan Jay history of Venkatesan Jay's purchases Director 589 $1.78 $1.0K SEC filing for Venkatesan Jay (opens in a new tab)
Total $78.0K

What happened next

A run ends after a pause in the buying, so one company can have several. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

After this run became a cluster: 21 days +11.0%63 days +24.0%126 days –